Placental niche and use thereof to culture stem cells

• US 20080044848A1
• Filed: 06/08/2007
• Published: 02/21/2008
• Est. Priority Date: 06/09/2006
• Status: Abandoned Application

• Current Assignee: Celularity, Inc.
• Original Assignee: Celularity, Inc.
• Inventors: Heidaran, Mohammad
• Application Number:
  US11/811,447
• Publication Number:
  US 20080044848A1
• Time in Patent Office: Days
• US Class Current: 435/29
• CPC Class Codes: A61L 27/3604 characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
• CPC Class Codes: A61L 27/3834 Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
• CPC Class Codes: C12N 2500/25 Insulin-transferrin; Insulin-transferrin-selenium
• CPC Class Codes: C12N 2500/36 Lipids
• CPC Class Codes: C12N 2501/11 Epidermal growth factor [EGF]
• CPC Class Codes: C12N 2501/135 Platelet-derived growth factor [PDGF]
• CPC Class Codes: C12N 2501/39 Steroid hormones
• CPC Class Codes: C12N 2533/92 Amnion; Decellularised dermis or mucosa
• CPC Class Codes: C12N 5/0605 Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly

Abstract

The present invention provides methods for culturing, expanding and differentiating stem cells, particularly human embryonic stem cells. The methods comprise culturing the stem cells for a period of time on a collagen biofabric, particularly a collagen biofabric derived from the amniotic membrane, chorion, or both, from mammalian placenta.

Claims

1. A method of culturing a stem cell comprising culturing the stem cell in a culture medium with a collagen biofabric, wherein said collagen biofabric is derived from a placenta, and said stem cell is exogenous to said collagen biofabric.

2. The method of claim 1 wherein said collagen biofabric comprises an amniotic membrane isolated from a mammalian placenta.

3. The method of claim 1 wherein said collagen biofabric comprises a chorion isolated from a mammalian placenta.

4. The method of claim 1 wherein said collagen biofabric comprises an amniotic membrane and a chorion from a mammalian placenta.

5. The method of claim 1, wherein said collagen biofabric is substantially dry prior to said culturing.

6. The method of claim 1, wherein said collagen biofabric is decellularized prior to said culturing.

7. The method of claim 1, wherein said collagen biofabric is not decellularized prior to said culturing.

8. The method of claim 1, wherein said collagen biofabric comprises cells endogenous to a placenta from which the collagen biofabric is derived.

9. The method of claim 1, wherein said collagen biofabric comprises cells exogenous to a placenta from which the collagen biofabric is derived.

10. The method of claim 8, wherein said collagen biofabric is irradiated.

11. The method of claim 9, wherein said collagen biofabric is irradiated.

12. The method of claim 1, wherein said stem cell is an embryonic stem cell.

13. The method of claim 1, wherein said stem cell is a placental stem cell.

14. The method of claim 1, wherein said stem cell is a mesenchymal stem cell, a hematopoietic stem cell, a placental blood- or umbilical cord blood-derived stem cell, a bone marrow-derived stem cell, or an adult somatic stem cell.

15. The method of claim 14, wherein said adult somatic stem cell is a neural stem cell, a hepatic stem cell, a pancreatic stem cell, an endothelial stem cell, a cardiac stem cell, or a muscle stem cell.

16. The method of claim 1, wherein said stem cell is cultured for 24 hours or more.

17. The method of claim 1, wherein said stem cell is cultured for two days or more.

18. The method of claim 1, wherein said stem cell is cultured for seven days or more.

36. The method of claim 1, wherein said collage biofabric comprises hyaluronic acid.

37. The method of claim 36, wherein said hyaluronic acid is crosslinked to said collagen biofabric.

19. A method of differentiating a stem cell comprising culturing said cell in culture medium with a collagen biofabric for a time sufficient for differentiation of the cell.

20. The method of claim 19, wherein said collagen biofabric comprises an amniotic membrane isolated from a mammalian placenta.

21. The method of claim 19, wherein said collagen biofabric comprises a chorion isolated from a mammalian placenta.

22. The method of claim 19, wherein said collagen biofabric comprises an amniotic membrane and a chorion from a mammalian placenta.

23. The method of claim 19, wherein said collagen biofabric is substantially dry prior to said differentiating.

24. The method of claim 19, wherein said collagen biofabric is decellularized prior to said differentiating.

25. The method of claim 19, wherein said collagen biofabric is not decellularized prior to said differentiating.

26. The method of claim 19, wherein said collagen biofabric comprises cells endogenous to a placenta from which the collagen biofabric is derived.

27. The method of claim 19, wherein said collagen biofabric comprises cells exogenous to a placenta from which the collagen biofabric is derived.

28. The method of claim 19, further comprising culturing a somatic cell on said collagen biofabric.

29. The method of claim 19, wherein said stem cell is an embryonic stem cell.

30. The method of claim 19, wherein said stem cell is a placental stem cell.

31. The method of claim 19, wherein said stem cell is a mesenchymal stem cell, a hematopoietic stem cell, a placental blood- or umbilical cord blood-derived stem cell, a bone marrow-derived stem cell, or an adult somatic stem cell.

32. The method of claim 31, wherein said adult somatic stem cell is a neural stem cell, a hepatic stem cell, a pancreatic stem cell, an endothelial stem cell, a cardiac stem cell, or a muscle stem cell.

33. The method of claim 19, wherein said cell is differentiated into a neural cell, an adipocyte, a chondrocyte, an osteocyte, a hepatocyte, a pancreatic cell, or a cardiac cell.

34. A method of determining the toxicity of a compound to a cell, comprising culturing said cell with a collagen biofabric under conditions suitable for the survival of the cell;

contacting said cell with the compound; and

identifying a change in a metabolic parameter of said cell indicating apoptosis, necrosis, or cell death, or a tendency towards apoptosis, necrosis or cell death, as compared to a cell cultured under equivalent conditions and not contacted with said compound, wherein if said change is identified, said compound is toxic to said cell.

35. A method of culturing a stem cell, comprising culturing the stem cell with a collagen biofabric comprising a plurality of placental stem cells;

and culturing said stem cell under conditions appropriate for the survival of the stem cell.